Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Gumuzio

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Stem Cells Translational Medicine|February 14, 2017
Linking Pluripotency Reprogramming and CancerJuan Manuel Iglesias, Juan Gumuzio, Angel G Martin
Oncotarget|September 24, 2014
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cellsBruna Corominas-Faja, Elisabet Cuyàs, Juan Gumuzio, et al.
Aging|March 20, 2020
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypesElisabet Cuyàs, Juan Gumuzio, Sara Verdura, et al.
Frontiers in Oncology|November 22, 2014
The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic PotentialJuan Manuel Iglesias, Olatz Leis, Estíbaliz Pérez Ruiz, et al.
Aging|November 10, 2020
Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activityElisabet Cuyàs, Juan Gumuzio, Jesús Lozano-Sánchez, et al.
Nutrients|July 24, 2019
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1AElisabet Cuyàs, Juan Gumuzio, Jesús Lozano-Sánchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2023
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung CancerLissete Sánchez-Magraner, Juan Gumuzio, James Miles, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Stem Cells Translational Medicine|February 14, 2017
Linking Pluripotency Reprogramming and CancerJuan Manuel Iglesias, Juan Gumuzio, Angel G Martin
Oncotarget|September 24, 2014
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cellsBruna Corominas-Faja, Elisabet Cuyàs, Juan Gumuzio, et al.
Aging|March 20, 2020
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypesElisabet Cuyàs, Juan Gumuzio, Sara Verdura, et al.
Frontiers in Oncology|November 22, 2014
The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic PotentialJuan Manuel Iglesias, Olatz Leis, Estíbaliz Pérez Ruiz, et al.
Aging|November 10, 2020
Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activityElisabet Cuyàs, Juan Gumuzio, Jesús Lozano-Sánchez, et al.
Nutrients|July 24, 2019
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1AElisabet Cuyàs, Juan Gumuzio, Jesús Lozano-Sánchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2023
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung CancerLissete Sánchez-Magraner, Juan Gumuzio, James Miles, et al.
Pageof 1